Latest News of ALX
We're Hopeful That DigitalX (ASX:DCC) Will Use Its Cash Wisely
While unprofitable companies pose risks due to potential cash burn, it's possible for shareholders to profit if they invest wisely. DigitalX's cash runway indicates 16 months, but its increasing cash ...
Alumexx (AMS:ALX) Is Doing The Right Things To Multiply Its Share Price
Alumexx shows promising trends with a 12% ROCE, indicating improved profitability and reinvestment opportunities. The company has seen substantial growth in returns on capital employed and decreased r...
QuantalX introduces Delphi-MD device for Parkinson's disease
QuantalX Neuroscience's Delphi-MD device offers early detection and subtyping of Parkinson's disease through direct electrophysiological imaging technology, aiding in tailored treatment plans. This in...
-
Investors in Alexanderwerk (FRA:ALXA) have seen splendid returns of 122% over the past five years
By Yahoo! Finance | 3 weeks agoDespite a recent 11% share price drop, Alexanderwerk has shown strong returns over the past five years, with a 66% increase. The company's EPS growth aligns closely with its share price growth, indica...
-
Investors in Calix (NYSE:CALX) have seen massive returns of 448% over the past five years
By Yahoo! Finance | 1 month agoInvesting in top-performing businesses like Calix, Inc. can lead to significant wealth accumulation over time. With a 448% share price increase in the last five years and 20% annual revenue growth, Ca...
-
Millennium Management LLC Reduces Stake in ALX Oncology Holdings Inc
By Yahoo! Finance | 1 month agoMillennium Management LLC reduced its stake in ALX Oncology Holdings Inc, a biotech company, by 959,297 shares at $1.82 per share, maintaining a 3.80% position....
-
Is Alumexx N.V. (AMS:ALX) A High Quality Stock To Own?
By Yahoo! Finance | 1 month agoThis article explains how Return On Equity (ROE) can help evaluate a company's performance using Alumexx N.V. as an example. ROE measures a company's profitability in relation to shareholders' equity....
-
Healx, an AI-enabled drug discovery platform for rare diseases, raises $47M | TechCrunch
By TechCrunch | 3 months agoUK-based startup Healx, using AI for drug discovery in rare diseases, raised $47 million in Series C funding led by Atomico and R42. The company obtained regulatory approval for Phase 2 clinical trial...
-
Is Alexanderwerk Aktiengesellschaft's (FRA:ALXA) Recent Performance Tethered To Its Attractive Financial Prospects?
By Yahoo! Finance | 4 months agoAlexanderwerk's stock has risen by 1.9% in the past week, prompting an analysis of its Return on Equity (ROE). With an ROE of 32%, the company's profitability and growth potential are highlighted....
-
Insider Buying: CFO Peter Garcia Acquires Shares of ALX Oncology Holdings Inc (ALXO)
By Yahoo! Finance | 5 months agoPeter Garcia, CFO of ALX Oncology Holdings Inc, purchased 12,000 shares of the company, now owning 122,348 shares. The company focuses on cancer treatment therapies, with a market cap of $432.431 mill...